T1	p 62 76	insufficiently
T2	p 241 297	patients with open angle glaucoma or ocular hypertension
T3	p 426 457	. 53 patients with primary open
T4	p 495 525	or ocular hypertension with an
T5	p 561 585	therapy were recruited .
T6	p 663 671	patients
T7	p 1186 1194	patients
T8	p 1276 1284	patients
T9	i 38 49	latanoprost
T10	i 91 100	timolol .
T11	i 162 163	)
T12	i 167 189	switching from timolol
T13	i 193 204	latanoprost
T14	i 215 237	latanoprost to timolol
T15	i 342 351	timolol .
T16	i 475 492	capsular glaucoma
T17	i 631 638	timolol
T18	i 641 654	5 mg/ml twice
T19	i 723 771	continued on timolol , one switched from timolol
T20	i 775 786	latanoprost
T21	i 842 856	latanoprost in
T22	i 869 878	timolol .
T23	i 1126 1133	timolol
T24	i 1208 1219	latanoprost
T25	i 1299 1308	treatment
T26	i 1318 1340	latanoprost to timolol
T27	i 1393 1415	switching from timolol
T28	i 1419 1430	latanoprost
T29	i 1578 1589	latanoprost
T30	i 1614 1621	timolol
T31	i 1690 1702	from timolol
T32	i 1706 1717	latanoprost
T33	o 135 176	intraocular pressure ( IOP ) of switching
T34	o 883 891	efficacy
T35	o 926 927	9
T36	o 984 990	IOP at
T37	o 1349 1352	IOP
T38	o 1393 1402	switching
T39	o 1522 1535	IOP reduction
T40	o 1645 1658	IOP reduction
T41	o 1680 1689	switching